Poly ICLC
| Combination of | |
|---|---|
| Clinical data | |
| Identifiers | |
 | |
| L03AX08 | |
| (what is this?) (verify) | |
Poly ICLC is an immunostimulant.
It consists of carboxymethylcellulose, polyinosinic-polycytidylic acid, and poly-L-lysine double-stranded RNA.[1]
It is a ligand for toll like receptor-3.[2]
References
- ↑ "Definition of poly ICLC - National Cancer Institute Drug Dictionary". Retrieved 2007-11-13.
- ↑ Zhu X, Nishimura F, Sasaki K et al. (2007). "Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models". Journal of translational medicine 5: 10. doi:10.1186/1479-5876-5-10. PMC 1802742. PMID 17295916.
External links
- National Cancer Institute: poly ICLC
| ||||||||||||||||||||||||||||||||||||||||||||||||